- Report
- January 2022
- 200 Pages
Global
From €7150EUR$7,500USD£6,094GBP
- Report
- January 2022
- 200 Pages
Global
From €7150EUR$7,500USD£6,094GBP
- Report
- May 2020
- 482 Pages
Global
From €9057EUR$9,500USD£7,720GBP
- Report
- May 2020
- 100 Pages
Global
From €2717EUR$2,850USD£2,316GBP
- Report
- May 2020
- 100 Pages
Global
From €2717EUR$2,850USD£2,316GBP
- Report
- January 2022
- 200 Pages
Global
From €7150EUR$7,500USD£6,094GBP
- Report
- December 2022
- 112 Pages
Global
From €4671EUR$4,900USD£3,982GBP
- Report
- January 2022
- 200 Pages
Global
From €7150EUR$7,500USD£6,094GBP
- Report
- January 2022
- 200 Pages
Global
From €7150EUR$7,500USD£6,094GBP
- Report
- May 2020
- 100 Pages
Global
From €2717EUR$2,850USD£2,316GBP
- Report
- October 2021
- 112 Pages
Global
From €4290EUR$4,500USD£3,657GBP
- Report
- April 2023
- 115 Pages
Global
From €4528EUR$4,750USD£3,860GBP
- Report
- April 2023
- 110 Pages
Global
From €4528EUR$4,750USD£3,860GBP
- Report
- April 2023
- 110 Pages
Global
From €4528EUR$4,750USD£3,860GBP
- Report
- July 2023
- 127 Pages
Australia
From €2002EUR$2,100USD£1,706GBP
€2860EUR$3,000USD£2,438GBP
- Report
- February 2018
- 103 Pages
Global
From €3337EUR$3,500USD£2,844GBP
- Report
- November 2020
- 49 Pages
Global
€1257EUR$1,318USD£1,071GBP
- Report
- April 2021
- 40 Pages
Global
From €3809EUR$3,995USD£3,246GBP
- Report
- March 2020
- 141 Pages
Global
From €7622EUR$7,995USD£6,497GBP
- Clinical Trials
- January 2020
- 658 Pages
Global
From €2383EUR$2,500USD£2,031GBP
Lung cancer is a type of cancer that originates in the lungs. It is the leading cause of cancer-related death worldwide. Oncology is the branch of medicine that deals with the diagnosis, treatment, and prevention of cancer. Lung cancer is one of the most common types of cancer treated by oncologists. Treatment options for lung cancer include surgery, chemotherapy, radiation therapy, and targeted therapy.
The lung cancer market is a rapidly growing segment of the oncology market. It is driven by the increasing prevalence of lung cancer, advances in treatment options, and the increasing availability of targeted therapies. The market is expected to continue to grow in the coming years due to the increasing demand for better treatments and the development of new therapies.
Some companies in the lung cancer market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more